Inflammatory Bowel Disease

Human In Vitro IBD Models.

Mouse models miss the biology that drives human IBD. RepliGut® gives you human gut tissue that reflects it, so your discoveries translate.

Discuss your IBD studyExplore the platform
The challenge

Why IBD drug discovery keeps failing

For decades, IBD drug discovery has leaned on mouse models. Rodents mimic some inflammatory pathways. But they cannot reflect the genetic, immune, and microbiome interactions that drive human disease.

The result is a high clinical failure rate. Drugs that look effective in animals often fail in patients. To close that gap, researchers need predictive, human-relevant in vitro IBD models that replicate the intestinal environment of the disease.

Mouse models vs RepliGut®

Mouse models vs human in vitro IBD models

The differences are not cosmetic. Mouse and human guts run on different immune and epithelial biology, and that changes what a drug actually does.

A cautionary tale

In preclinical models, blocking IL-17 looked like a promising way to calm gut inflammation. In a human Crohn's disease trial, the anti-IL-17A antibody secukinumab failed to help, was linked to more adverse events, and showed signs of worsening disease, so the study was stopped early. IL-17 turns out to help protect the human gut barrier, a human-specific role the animal models never revealed.

Read the trial
What mattersMouse modelsRepliGut® human models
Immune & epithelial biologyMouse Paneth cells secrete over 20 alpha-defensins; humans secrete two, and neutrophil biology differsHuman epithelium with human defensin, cytokine, and barrier biology
How disease is createdForced with chemicals or single-gene knockouts that no patient actually hasHuman donor tissue that reflects real human variation
Microbiome & immune makeupA different microbiome and different immune cell ratios than humansHuman epithelium you can challenge with human-relevant signals
Human repair biologyMiss human regeneration such as YAP and Wnt dynamicsObserve human intestinal repair directly with RepliGut® Crypt
Clinical translationEfficacy in rodents frequently fails to reach patientsBuilt from human tissue to predict the human response
Throughput & donorsLow, slow, and hard to varyHigh-throughput screening across multiple human donors
What you can study

What in vitro IBD models let you measure

Assess barrier integrity

through TEER and permeability measurements.

Model inflammatory responses

with cytokines like TNF-α, IFN-γ, and IL-1β.

Test drug mechanisms of action

on barrier repair, inflammation, and epithelial health.

Capture donor-to-donor variability

to evaluate treatment-response diversity.

Compare regional differences

across duodenum, jejunum, ileum, and colon.

Investigate epithelial-microbiome interactions

with microbial metabolites and bacterial components.

Study wound healing

to track epithelial restitution after injury.

Discover biomarkers

of disease progression and therapeutic efficacy.

RepliGut Immune Co-Culture model of immune-epithelial interaction for IBD

Add immune cells with RepliGut® Immune Co-Culture

IBD is driven by immune-epithelial cross-talk. RepliGut® Immune Co-Culture places human immune cells beneath the epithelium, so you can study that interaction directly. It is one of the most popular starting points for our IBD customers.

Explore Immune Co-Culture
The regulatory shift

Why in vitro IBD models matter now

In 2025, the FDA and NIH announced a shift away from animal testing toward New Approach Methodologies (NAMs). NAMs include human-relevant assays, organ-on-chip systems, and advanced in vitro models.

For a disease like IBD, animal models often miss the mark. That shift makes human, physiologically accurate platforms essential.

In vitro IBD model of human intestinal epithelial repair and wound healing
The unmet need

Modeling human intestinal repair

A central challenge in IBD is how the gut heals itself: stem cell activation, epithelial regeneration, and immune-epithelial cross-talk. Animal models miss human-specific processes, such as YAP and Wnt signaling dynamics and cellular plasticity during regeneration.

With RepliGut® Crypt, you can directly observe and manipulate human intestinal regeneration, including fetal-like dedifferentiation and epithelial restitution. These are phenomena that animal models cannot reproduce.

Explore RepliGut® Crypt
Get started

Kits or full-service IBD studies

RepliGut® Kits

Run human IBD models in your own lab, complete with cells, plates, media, and technical support.

Explore kits

Full-service studies

Have our scientists design and run the study, from inflammation induction to barrier and repair readouts.

Explore services

Ready to model IBD in human tissue?

Tell us what you are trying to answer, and we will help you build the right in vitro IBD model for your program.

Talk to our team